123 related articles for article (PubMed ID: 7041239)
1. An artificial betacell: assessment of the glucose analyser, infusion system and optimization of constants for the algorithms.
Christiansen JS; Svendsen PA; Søegaard U; Frandsen M; Mathiesen E; Winther K; Deckert T
Scand J Clin Lab Invest; 1981 Nov; 41(7):647-54. PubMed ID: 7041239
[TBL] [Abstract][Full Text] [Related]
2. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
Christiansen JS; Svendsen PA; Deckert T
Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
[TBL] [Abstract][Full Text] [Related]
3. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).
Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H
Diabetologia; 1982 Sep; 23(3):220-8. PubMed ID: 6751902
[TBL] [Abstract][Full Text] [Related]
4. Studies on the clinical importance of the constants used in the algorithm of an artificial B-cell (Biostator).
Ratzmann KP; Jutzi E; Albrecht G
Z Exp Chir Transplant Kunstliche Organe; 1983; 16(5):270-6. PubMed ID: 6359740
[TBL] [Abstract][Full Text] [Related]
5. [Insulin needs of insulin-dependent diabetics during biostator control and subcutaneous use of insulin].
Petkova M; Khristov V; Tsanev A
Vutr Boles; 1990; 29(1):74-7. PubMed ID: 2204207
[TBL] [Abstract][Full Text] [Related]
6. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics.
Mayfield RK; Sullivan FM; Colwell JA; Wohltmann HJ
Diabetes; 1983 Oct; 32(10):908-14. PubMed ID: 6352376
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy.
Christiansen JS; Svendsen PA; Mathiesen E; Rubin P; Deckert T
Horm Metab Res; 1981 Oct; 13(10):537-41. PubMed ID: 7028586
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and hormonal responses during a glucose controlled insulin infusion (Biostator) in subjects with impaired glucose tolerance.
Ratzmann KP; Schneider U; Peters U; Ziegler M; Schulz B
Exp Clin Endocrinol; 1984 May; 83(3):334-42. PubMed ID: 6381073
[TBL] [Abstract][Full Text] [Related]
9. Diurnal rhythm of insulin sensitivity in subjects with normal and impaired glucose tolerance.
Schulz B; Ratzmann KP; Albrecht G; Bibergeil H
Exp Clin Endocrinol; 1983 May; 81(3):263-72. PubMed ID: 6350027
[TBL] [Abstract][Full Text] [Related]
10. Use of the artificial B-cell (Biostator) in improving insulin therapy in unstable insulin-dependent diabetes.
Ratzmann KP; Bruns W; Schulz B; Zander E
Diabetes Care; 1982; 5(1):11-7. PubMed ID: 6754298
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of dawn phenomenon without change in insulin clearance in patients with insulin-dependent diabetes mellitus.
Campbell PJ; Gerich JE
Diabetes; 1986 Jul; 35(7):749-52. PubMed ID: 3522315
[TBL] [Abstract][Full Text] [Related]
12. Diurnal pattern of insulin requirements in insulin-dependent diabetics.
Mathiesen ER; Rubin P; Sandahl Christiansen J; Aaby Svendsen P; Lauritzen T; Deckert T
Scand J Clin Lab Invest; 1982 Feb; 42(1):63-8. PubMed ID: 6753093
[TBL] [Abstract][Full Text] [Related]
13. [Normoglycemic control by artificial pancreas in patients with pancreatic diabetes or with primary diabetes mellitus--analysis of patterns of insulin infusion and nocturnal glucose infusion].
Yoshida Y; Koizumi M; Abe N; Ishizuka J; Sanoyama K; Goto Y
Nihon Shokakibyo Gakkai Zasshi; 1989 Mar; 86(3):786-92. PubMed ID: 2770020
[TBL] [Abstract][Full Text] [Related]
14. 24-hour blood glucose profiles in insulin-dependent diabetics treated with intravenous insulin infusion systems. A comparison between closed- and open-loop systems.
Deckert T; Bojsen J; Christiansen JS; Kølendorf K; Svendsen PA; Andersen AR
Acta Med Scand; 1980; 208(6):451-8. PubMed ID: 7008508
[TBL] [Abstract][Full Text] [Related]
15. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
Kerner W; Beischer W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
[TBL] [Abstract][Full Text] [Related]
16. Short-term of the artificial beta-cell (Biostator) on pancreatic glucagon response in insulin-dependent diabetic (IDDM).
Ratzmann KP; Schneider U; Besch W; Heinke P
Exp Clin Endocrinol; 1984 Jul; 84(1):91-8. PubMed ID: 6383851
[TBL] [Abstract][Full Text] [Related]
17. Glucose clamps with the Biostator: a critical reappraisal.
Heinemann L; Ampudia-Blasco FJ
Horm Metab Res; 1994 Dec; 26(12):579-83. PubMed ID: 7705762
[TBL] [Abstract][Full Text] [Related]
18. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
DeFronzo R; Deibert D; Hendler R; Felig P; Soman V
J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
[TBL] [Abstract][Full Text] [Related]
19. Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose.
Goodner CJ; Conway MJ; Werbach JH
J Clin Invest; 1969 Oct; 48(10):1878-87. PubMed ID: 5822593
[TBL] [Abstract][Full Text] [Related]
20. Preprogrammed insulin infusion with a portable pump system.
Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
